Status:
UNKNOWN
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
Lead Sponsor:
Ziv Hospital
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Background: Among individuals with schizophrenia, there is an increased prevalence of obesity, dyslipidemia ,diabetes mellitus and related conditions such as cardiovascular disease. People with sever...
Eligibility Criteria
Inclusion
- in patients and outpatients with schizophrenia, schizoaffective and bipolar disorder based on psychiatrist diagnostic evaluation using DSM-IV criteria, before and at least two months after antipsychotic therapy will be enrolled.
Exclusion
- Unwillingness to participate in the study.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01215383
Start Date
November 1 2010
Last Update
February 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziv Medical Center (Government Hospital)
Safed, Israel, 13110